At the ASCB | EMBO 2017 meeting, we introduced z-Movi®, a new platform for cell interaction studies. This new method enables direct and label-free screening and sorting of thousands of cells based on their interaction with cell or protein targets. z-Movi® is a breakthrough technology for research and development of personalized therapies, including immunotherapy. It is…
Jerom Langeveld5 December 2017